Psychedelic, a term coined by Canadian psychiatrist Humphry Osmond in the mid-1950s, means “mind-manifesting” and refers to a type of psychotropic drug in a class entirely of its own. 

Psilocybin has a pharmacological effect of profoundly altering consciousness. This feature when used properly may be a major component in its remarkable ability to treat an ever-growing set of psychiatric conditions.

“The biggest blow to the overall economy are the many hidden, indirect costs. People with serious mental illness earn, on average, $16,000 less than their mentally well counterparts, totaling about $193 billion annually in lost earnings.”

The American Journal of Psychiatry

Psychedelic medicine: a re-emerging therapeutic paradigm gaining popularity worldwide.

Research Organizations are Leading Psychedelic Studies

Centre for Psychedelic Research
Center for Psychedelic Research
Compassion Investigating Mental Health
Imperial College London
Beckley Foundation

Psychedelic Therapeutics – Distribution by Target Therapeutic Area

Depression and Anxiety Disorder
Substance Abuse Disorder
Sleep Disorder
Chronic Brain Disorder
Multiple Disorder
Mycologistics About Research

Psychedelic Drugs Market Projected to Reach $6.85 Billion by 2027

Market Size USD

Growth in Psychedelic Research: A Step in the Right Direction

Correcting Mental Health Issues with non-habit forming medications heals us all.